End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.75 CNY | +1.93% | +1.50% | -11.21% |
Business Summary
China accounts for 86.3% of net sales.
Number of employees: 6,214
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Other
42.9
%
| 3,745 | 42.5 % | 3,539 | 42.9 % | -5.52% |
Preparation
41.3
%
| 3,593 | 40.8 % | 3,408 | 41.3 % | -5.15% |
Raw Material
15.7
%
| 1,470 | 16.7 % | 1,296 | 15.7 % | -11.84% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 8,809 | 100.0 % | 8,243 | 100.0 % | -6.42% |
Managers
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Li Qin Chen
BRD | Director/Board Member | 59 | 21-11-16 |
Kai Zhou
CEO | Chief Executive Officer | 60 | 05-04-30 |
Zhao Chun Tan
BRD | Director/Board Member | 59 | 21-11-16 |
Zhi Hua Huang
BRD | Director/Board Member | 56 | 21-11-16 |
Cheng Ren Huang
BRD | Director/Board Member | 60 | 18-07-17 |
Xin Hua Ao
BRD | Director/Board Member | 60 | 18-07-17 |
Demin Han
BRD | Director/Board Member | 73 | 18-07-17 |
Hui Yao
BRD | Director/Board Member | 60 | 18-07-17 |
Bai Dan Zhan
CHM | Chairman | 50 | 18-12-26 |
Jian Min Guo
CHM | Chairman | 53 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,429,103,265 | 596,135,801 ( 41.71 %) | 40,765,000 ( 2.852 %) | 41.71 % |
Company contact information
Northeast Pharmaceutical Group Co., Ltd.
Shenyang Economics & Tech Dev Zone 8, Kunming Lake Street
110027, Shenyang
+86 24 2580 6963
http://www.nepharm.com.cnSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-11.21% | 938M | |
+33.25% | 704B | |
+28.59% | 577B | |
-3.55% | 348B | |
+18.16% | 327B | |
+4.36% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.69% | 147B |
- Stock Market
- Equities
- 000597 Stock
- Company Northeast Pharmaceutical Group Co., Ltd.